Every EDGAR filing for MapLight Therapeutics, Inc. (MPLT), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 6 open-market sales ($1.1M).
Erin Pennock Foff, insider filing for MPLT
Erin Pennock Foff, reporting
Kristopher Hanson, planned sale of MPLT shares
Kristopher Hanson, reporting
Kristopher Hanson, insider filing for MPLT
Kristopher Hanson, reporting
Kristopher Hanson, planned sale of MPLT shares
Kristopher Hanson, reporting
Ownership stake disclosure by Pivotal bioVenture Partners Fund II, L.P.
Pivotal bioVenture Partners Fund II, L.P., filed by
Erin Pennock Foff, insider filing for MPLT
Erin Pennock Foff, reporting
Catalyst4, Inc., insider filing for MPLT
Catalyst4, Inc., reporting
Ownership stake disclosure by Catalyst4, Inc. (amended)
Catalyst4, Inc., filed by
James Woodruff Lillie, insider filing for MPLT
James Woodruff Lillie, reporting
Ownership stake disclosure by Catalyst4, Inc. (amended)
Catalyst4, Inc., filed by
James Woodruff Lillie, planned sale of MPLT shares
James Woodruff Lillie, reporting
Ownership stake disclosure by Novo Holdings A/S (amended)
Novo Holdings A/S, filed by
Novo Holdings A/S, planned sale of MPLT shares
Novo Holdings A/S, reporting
Catalyst4, Inc., insider filing for MPLT
Catalyst4, Inc., reporting
Troy Cox, insider filing for MPLT
Troy Cox, reporting
Jonathan Gillis, insider filing for MPLT
Jonathan Gillis, reporting
Christopher A. Kroeger, insider filing for MPLT
Christopher A. Kroeger, reporting
Anatol Kreitzer, planned sale of MPLT shares
Anatol Kreitzer, reporting
Anatol Kreitzer, planned sale of MPLT shares (amended)
Anatol Kreitzer, reporting
Jonathan Gillis, planned sale of MPLT shares
Jonathan Gillis, reporting
Erin Pennock Foff, planned sale of MPLT shares
Erin Pennock Foff, reporting